Single Amino Acid Change in Snake Venom Peptides Dramatically Alters Cancer-Killing and Antibacterial Properties

Two 13-mer snake venom peptides differing by a single leucine/phenylalanine substitution showed dual anticancer and antibacterial activity, with phenylalanine conferring significantly stronger effects against osteosarcoma.

Almeida, José R et al.·Current issues in molecular biology·2021·Preliminary Evidencein_vitro
RPEP-05260In_vitroPreliminary Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in_vitro
Evidence
Preliminary Evidence
Sample
N=Not applicable (lab study)
Participants
Two synthetic 13-mer venom-derived peptides tested against bacteria and cancer cells

What This Study Found

Both p-AppK and p-Acl showed dual antibacterial (including MDR strains) and anticancer activity without hemolysis. The leucine→phenylalanine substitution in p-Acl significantly enhanced activity, particularly against osteosarcoma (HOS, MG63) cells.

Key Numbers

Single Leu/Phe substitution; one peptide primarily antibacterial, the other primarily anticancer.

How They Did This

Peptide synthesis and characterization. Antibacterial MIC testing against Gram-positive and Gram-negative bacteria including MDR strains. Anticancer cytotoxicity against solid and liquid tumors. Hemolysis assays. Molecular dynamics simulations for mechanism. DNA-intercalating dye uptake for membrane permeability.

Why This Research Matters

A single amino acid change dramatically altering drug properties demonstrates how natural peptide variation can be leveraged for drug design. The dual cancer/infection-fighting activity without blood cell toxicity makes these promising therapeutic candidates.

The Bigger Picture

Snake venom continues to be a treasure trove of bioactive peptides. Understanding how single amino acid changes fine-tune activity provides a powerful design principle for creating new antibiotics and anticancer agents from natural templates.

What This Study Doesn't Tell Us

In vitro study only — no animal model testing. The relationship between membrane disruption in vitro and therapeutic potential in vivo is complex. Selectivity between cancer and normal cells beyond red blood cells not fully characterized.

Questions This Raises

  • ?Would p-Acl show anti-osteosarcoma efficacy in animal models?
  • ?Can this single-substitution optimization approach be applied to other venom-derived peptides?
  • ?What determines the selectivity between cancer/bacterial membranes and normal cell membranes?

Trust & Context

Key Stat:
1 amino acid leucine→phenylalanine substitution dramatically enhanced anticancer and antibacterial potency
Evidence Grade:
Thorough in vitro characterization with computational mechanistic support. Early drug discovery stage without animal testing.
Study Age:
Published in 2021. Venom-derived dual-action peptides continue to be explored for antimicrobial and anticancer applications.
Original Title:
Lessons from a Single Amino Acid Substitution: Anticancer and Antibacterial Properties of Two Phospholipase A2-Derived Peptides.
Published In:
Current issues in molecular biology, 44(1), 46-62 (2021)
Database ID:
RPEP-05260

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

How do these snake venom peptides kill cancer and bacteria?

They interact with and deform cell membranes, increasing permeability so that harmful molecules can enter the cell. Cancer and bacterial membranes have different compositions than normal cells, providing some selectivity.

Could a single amino acid change really make that much difference?

Yes — amino acid side chains determine how peptides interact with membranes. Phenylalanine is more hydrophobic and aromatic than leucine, allowing it to insert more deeply into membranes and enhance the peptide's disruptive effect.

Read More on RethinkPeptides

Cite This Study

RPEP-05260·https://rethinkpeptides.com/research/RPEP-05260

APA

Almeida, José R; Mendes, Bruno; Lancellotti, Marcelo; Franchi, Gilberto C; Passos, Óscar; Ramos, Maria J; Fernandes, Pedro A; Alves, Cláudia; Vale, Nuno; Gomes, Paula; da Silva, Saulo L. (2021). Lessons from a Single Amino Acid Substitution: Anticancer and Antibacterial Properties of Two Phospholipase A2-Derived Peptides.. Current issues in molecular biology, 44(1), 46-62. https://doi.org/10.3390/cimb44010004

MLA

Almeida, José R, et al. "Lessons from a Single Amino Acid Substitution: Anticancer and Antibacterial Properties of Two Phospholipase A2-Derived Peptides.." Current issues in molecular biology, 2021. https://doi.org/10.3390/cimb44010004

RethinkPeptides

RethinkPeptides Research Database. "Lessons from a Single Amino Acid Substitution: Anticancer an..." RPEP-05260. Retrieved from https://rethinkpeptides.com/research/almeida-2021-lessons-from-a-single

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.